Cart
sales@molnova.com
M1001
CAS No. 874590-32-6
M1001( —— )
Catalog No. M21074 CAS No. 874590-32-6
M1001 is a HIF-2α agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 79 | Get Quote |
|
| 5MG | 132 | Get Quote |
|
| 10MG | 222 | Get Quote |
|
| 25MG | 447 | Get Quote |
|
| 50MG | 651 | Get Quote |
|
| 100MG | 888 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameM1001
-
NoteResearch use only, not for human use.
-
Brief DescriptionM1001 is a HIF-2α agonist.
-
DescriptionM1001 is a HIF-2α agonist.
-
In VitroWestern Blot Analysis Cell Line:786-O cells Concentration:10?μM Incubation Time:Result:Increased the expression of HIF-2 target genes modestly in 786-O cells.Western Blot Analysis Cell Line:HEK293T cells Concentration:1 and 10?μM Incubation Time:Result:Reduced the physical association between HIF-2α and VHL.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorHIF-2α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number874590-32-6
-
Formula Weight327.4
-
Molecular FormulaC17H17N3O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL?(763.59 mM)
-
SMILESO=S1(=O)N=C(Nc2ccccc2N2CCCC2)c2ccccc21
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bidirectional Modulation of HIF-2 Activity through Chemical Ligands[C]// 中国生物化学与分子生物学会全国会员代表大会暨全国学术会议. 0.
molnova catalog
related products
-
KHS-101
KHS-101 (KHS101) is a small molecule that selectively induces a neuronal differentiation phenotype.
-
HIF2α-IN-1
A potent HIF-2α inhibitor with IC50 of <500 nM in HIF-2α scintillation proximity assay.
-
Naphthofluorescein
Naphthofluorescein （Naphthafluorescein） is a Mint3 inhibitor with potential antitumor and anti-inflammatory activities, inhibits the interaction between HIF-1 and Mint3, inhibits Mint3-dependent HIF-1 activity, and inhibits glycolytic activity in cancer cells and macrophages without showing significant in vitro cytotoxicity or in vivo side effects.
